Amanda L. Kong, MD, MS, FACS, FSSO, DABS
Professor
Locations
- Froedtert Hospital
- Breast Care Center - Clinical Cancer Center - Froedtert Hospital
- Cancer Center - Mequon Health Center
Specialties
- Surgical Oncology
Languages
- French, English
Education
- MD - Doctor of Medicine
- MS -Master of Science
- FACS - Fellow of the American College of Surgeons
- FSSO-Fellow of the Society of Surgical Oncology
- DABS - Diplomate of the American Board of Surgery
Biography
Amanda L. Kong, MD, MS, is a professor of surgery and section chief of breast surgery in the Division of Surgical Oncology, Department of Surgery at the Medical College of Wisconsin. Dr. Kong received her undergraduate degree at Brown University and her MD from the Warren Alpert Medical School of Brown University. She completed her general surgery residency at Mount Sinai Hospital in New York City followed by a Breast Surgical Oncology Fellowship at The University of Texas MD Anderson Cancer Center. She joined the Medical College of Wisconsin in 2008 as an assistant professor where she obtained a Master’s Degree in Epidemiology in 2010.
Dr. Kong is a member of many prestigious societies including the American Society of Breast Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the American College of Surgeons. She currently serves as the Vice Chair of the Breast Fellowship Training Committee of the Society of Surgical Oncology and is the State Chair for Wisconsin for the Commission on Cancer. Dr. Kong is also a member of the Editorial Board of the American Journal of Surgery.
Among her many honors, Dr. Kong has been awarded Best Doctor by M Magazine and Best Doctors in America. She has also been awarded the Medical College of Wisconsin Outstanding Medical Student Teaching Award several times as well as the Excellence in Professionalism Award from the faculty practice in 2016. Her research focuses on breast cancer disparities and outcomes, breast cancer care in the elderly, as well as improving the quality of life for breast cancer patients. She has published multiple peer reviewed articles and book chapters in addition to being a sought mentor to students and residents.
Clinical Expertise
- Breast
- Breast Diseases
- Breast Neoplasms
- Carcinoma, Ductal, Breast
Leadership Positions
- Section Chief, Breast Surgery
Research Interests
Dr. Kong is a breast surgical oncologist with a clinical and research focus in breast cancer and benign breast diseases. She joined the CAPS group (formerly known as PCOR) while completing her Master’s Degree in Epidemiology at the Medical College of Wisconsin. Her clinical practice provides the foundation for her research to help improve the care of her patients. She has an interest in quality of care and health care disparities with respect to breast cancer outcomes. Her current research focuses on the relationship between hospital volume and breast cancer care, including differences in processes of care in high- and low-volume hospitals and their impact on mortality through the use of large administrative databases and tumor registries. She also has a research focus on the treatment of older breast cancer patients, specifically balancing quality of life and maximizing treatment outcomes.
Publications
-
(Summerside M, Istl AC, Rogers CC, Cobb AN, Kong AL, Singh P, Cortina CS.) Ann Surg Oncol. 2025 Oct;32(11):8184-8191 PMID: 40684019 PMCID: PMC12355729 SCOPUS ID: 2-s2.0-105011267387 07/20/2025
-
Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer.
(Cobb AN, Dong X, Makope A, Cohen L, Huang CC, Kong AL, Cortina CS.) Ann Surg Oncol. 2025 Sep 29 PMID: 41023545 PMCID: PMC12558606 SCOPUS ID: 2-s2.0-105018229193 09/30/2025
-
(Do Couto N, Hidde M, Grigoriadis G, Sparapani R, Durand M, Widlansky M, Jankowski C, Berendt M, Canales B, Golus S, Norwood Toro LE, Laud P, Kong A, Hoskins K, Lewandowski D, Phillips SA, Gutterman DD, Kriegel AJ, Beyer KMM, Beyer AM, Stolley M.) Cardiooncology. 2025 Aug 21;11(1):75 PMID: 40841694 PMCID: PMC12369258 SCOPUS ID: 2-s2.0-105014033548 08/22/2025
-
Current insights into breast and ovarian cancer risk: a contemporary review.
(Gaughan NA, Rademacher N, Rogers C, Purdy A, Mattingly JD, Patten CR, Cobb AN, Kong AL, Cortina CS.) Minerva Surg. 2025 Aug;80(4):334-353 PMID: 40719430 PMCID: PMC12355728 SCOPUS ID: 2-s2.0-105012570688 07/28/2025
-
(Cohen LN, Rogers CC, Lloren JIC, Kamaraju S, Chaudhary LN, Huang CC, Cobb AN, Singh P, Kong AL, Teshome M, Cortina CS.) Breast Cancer Res Treat. 2025 Aug;212(3):531-543 PMID: 40459676 PMCID: PMC12213117 SCOPUS ID: 2-s2.0-105007155274 06/03/2025
-
Sentinel Node Biopsy Utilization in Wisconsin Women Undergoing Breast-Conserving Surgery for DCIS.
(Cortina CS, Schumacher JR, Cartmill RS, Venkatesh M, Lawson EH, Kong AL, Lautner MA.) Ann Surg Oncol. 2025 Aug;32(8):5446-5448 PMID: 40450165 PMCID: PMC12210222 SCOPUS ID: 2-s2.0-105007248299 06/01/2025
-
Should abemaciclib candidacy be an indication for ALND?-commentary on SENOMAC post-hoc analysis.
(Walker JC, Kong AL, Cortina CS.) Gland Surg. 2025 Apr 30;14(4):776-780 PMID: 40405951 PMCID: PMC12093160 05/23/2025
-
Are there differences in overall survival among older breast cancer patients by race and ethnicity?
(Cobb AN, Rogers C, Dong X, Huang CC, Kong AL, Cortina CS.) Surgery. 2025 Mar;179:108896 PMID: 39482112 PMCID: PMC11786985 SCOPUS ID: 2-s2.0-85208024576 11/01/2024
-
(Crown A, Kong AL.) Am J Surg. 2025 Feb;240:116013 PMID: 39443181 SCOPUS ID: 2-s2.0-85206971144 10/24/2024
-
Should abemaciclib candidacy be an indication for ALND?—commentary on SENOMAC post-hoc analysis
(Walker JC, Kong AL, Cortina CS.) Gland Surgery. 2025;14(4):776-780 SCOPUS ID: 2-s2.0-105004691132 01/01/2025
-
(Rogers C, Zeien S, Puccetti K, Jorns JM, Kong AL, Cherian S, Cortina CS.) Am J Surg. 2025 Jan;239:116047 PMID: 39481279 PMCID: PMC11650375 SCOPUS ID: 2-s2.0-85207766054 11/01/2024
-
Adjuvant breast radiation therapy practice patterns in the United States from 2012-2017.
(Gellings JA, Cortina CS, Kijak J, Bradley J, Aldakkak M, Bergom C, Kong AL.) Surg Oncol Insight. 2024 Dec;1(4) PMID: 39555478 PMCID: PMC11566854 11/18/2024